PD Prescription Low Transporter — ESENeph MCQ

Correct answer: E — Assess overall clinical status and residual function before changing prescription

The best answer is “Assess overall clinical status and residual function before changing prescription”. High-quality PD is judged from wellbeing, symptoms, volume and nutrition, residual function, biochemical control and treatment burden rather than a single Kt/V threshold. “Increase exchanges after reviewing symptoms, volume and residual function” is less appropriate because ISPD moved away from a single adequacy number as the sole target “Consider haemodialysis when clinical goals cannot be achieved with PD” is less appropriate because modality change should reflect the whole clinical and patient-goal assessment “Track residual kidney function as part of longitudinal prescription review” is less appropriate because serial residual function and clinical status still require review “Use hypertonic glucose selectively for clinically significant volume excess” is less appropriate because this adds glucose burden without a demonstrated ultrafiltration problem

Reference: UK Kidney Association peritoneal-dialysis guideline: https://ukkidney.org/sites/default/files/final-peritoneal-dialysis-guideline667ba231181561659443ff000014d4d8.pdf